U.S. Oil and Gas Stock News

Wondering if Yum! Brands at around US$153.96 is still a fair deal or starting to look stretched? This article walks through what the current price might actually be implying. The stock is up 2.3% year to date and 0.7% over the past year, although the share price has seen an 8.4% pullback over 30 days and a 1.6% slip over the last week, which may have changed how the market is thinking about risk and reward. Recent attention around Yum! Brands has focused on its position as a major global...

Event context and recent share performance Amkor Technology (AMKR) has drawn investor attention after recent share price moves, with the stock down about 7% over the past month but up roughly 11% in the past 3 months. See our latest analysis for Amkor Technology. At a share price of $44.45, Amkor’s recent 7% 1 month share price decline contrasts with a stronger 10.9% 3 month share price return and very large 1 year total shareholder return. This suggests that earlier momentum is cooling in...

What recent performance says about Pitney Bowes (PBI) Pitney Bowes (PBI) has drawn investor attention after a period where the stock showed mixed short term moves, including a 1 day decline of 0.7% and gains over the past week and year. See our latest analysis for Pitney Bowes. The recent 6.7% 7 day share price return, alongside a 5.2% year to date share price gain and a 214% three year total shareholder return, points to momentum that has been building rather than fading. If Pitney Bowes has...

REX American Resources reported past fourth-quarter 2025 sales of US$157.96 million, with net income rising to US$43.75 million, and full-year 2025 sales of US$650.49 million alongside net income of US$82.95 million. Record earnings per share, record ethanol sales volumes, substantial US$28.00 million in 45Z tax credits, and progress on capacity expansion and carbon capture projects collectively reshaped the company’s earnings mix and growth profile. We’ll now examine how record 2025...

Why the latest ONWARD data matters for Alumis stock Alumis (ALMS) is in focus after releasing detailed Phase 3 ONWARD1 and ONWARD2 results for envudeucitinib in moderate to severe plaque psoriasis, paired with plans for a U.S. FDA New Drug Application this year. The data set highlights skin clearance rates, quality of life measures, and a 24 week safety profile in more than 1,700 patients. It has been featured in a late breaking oral session at the 2026 American Academy of Dermatology...

What stands out about Welltower right now Welltower (WELL) sits at the center of what it calls the silver economy, with a portfolio of more than 2,000 seniors and wellness housing communities across the United States, United Kingdom and Canada. At a recent share price of US$195.77 and a market value of about US$136.6b, the company reports annual revenue of US$10.84b and net income of US$936.85m, primarily from seniors housing operating assets. See our latest analysis for Welltower. Recent...

Why Citigroup (C) is Back on Investors’ Radar Citigroup (C) is drawing attention after a stretch of weaker recent share performance, with the stock showing negative returns over the past week, month, past 3 months and year to date. See our latest analysis for Citigroup. Despite a recent 1-day share price return of negative 4.47% and a weaker 90-day share price return of negative 9.10%, Citigroup’s longer term total shareholder returns of 56.65% over 1 year and 154.22% over 3 years suggest...

Labor rally puts Neogen (NEOG) workforce issues in focus Warehouse workers at Neogen (NEOG) in Lansing, Michigan, represented by Teamsters Local 243, are planning a March 27 rally over alleged unfair labor practices, seeking improved pay, workplace respect, and stronger representation. This organizing effort draws attention to potential labor related risks for Neogen, including the possibility of higher wage costs or short term operational friction. Some investors may weigh these...

Framing Solventum after recent share price moves Solventum (SOLV) has come under pressure recently, with the share price weaker over the past week, month, and past 3 months. This has prompted investors to reassess how the healthcare group’s fundamentals line up with current market pricing. See our latest analysis for Solventum. At a current share price of US$62.76, Solventum’s recent 1 month share price return of 15.42% and year to date share price return of 20.58% suggest momentum has been...

SoFi Technologies expanded its Loan Platform Business with three new partnerships tied to more than $3.6b of personal loans. The agreements involve a global bank, a financial services and insurance group, and a top five global private asset manager. The deals are structured around a capital light, fee based lending platform that supports recurring non interest income. For investors tracking NasdaqGS:SOFI, this move puts fresh attention on the loan platform side of the business rather than...

We'd be surprised if Datavault AI Inc. ( NASDAQ:DVLT ) shareholders haven't noticed that the Chairman & CFO, Brett...

Today is shaping up negative for LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders, with the analysts delivering a...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Tron ( NASDAQ:TRON...

We wouldn't blame TMC the metals company Inc. ( NASDAQ:TMC ) shareholders if they were a little worried about the fact...

TeraWulf Stock: Key Signals After Recent Performance Swings TeraWulf (WULF) has drawn fresh attention after a sharp 1 year total return of 447.43%, alongside a loss of 8.20% over the past month and a 30.39% gain in the past 3 months. See our latest analysis for TeraWulf. For TeraWulf, the recent 30.39% 3 month share price return contrasts with a softer 30 day share price return of 8.20% decline, which hints that shorter term momentum is cooling even as the very large 1 year total shareholder...

German American Bancorp, Inc. has approved an amendment to its Amended and Restated Articles of Incorporation to increase authorized common stock from 45,000,000 to 90,000,000 shares, as set out ahead of its 2026 Annual Meeting of Shareholders held on April 27, 2026. This doubling of authorized shares gives the bank far more flexibility around potential future capital raising, acquisitions, or stock-based corporate actions that could reshape its long-term capital structure. Next, we’ll...

Middleby has appointed Brittany Cerwin as its new Chief Financial Officer to lead the finance function during a major portfolio transformation. Outgoing CFO Bryan Mittelman will transition to a Special Advisor role and focus on the planned spin off of Middleby’s Food Processing business. The leadership change comes as Middleby prepares to position itself as a more focused commercial foodservice company. For investors watching NasdaqGS:MIDD, this leadership shift lands after a challenging...

If you are wondering whether J. M. Smucker is starting to look attractively priced or still has room to fall, the recent share moves invite a closer look at what you are really paying for. The stock last closed at US$95.24, with returns of 4.2% decline over 7 days, 17.9% decline over 30 days, 1.4% decline year to date, 14.8% decline over 1 year, 32.4% decline over 3 years, and 10.8% decline over 5 years. Recent coverage has focused on how sentiment around packaged foods companies is...

Recent share performance and what it may signal for investors Novavax (NVAX) has seen mixed share performance recently, with a 5.6% decline over the past day and a 12.2% decline over the past week, in contrast to a 23.9% gain over the past 3 months. See our latest analysis for Novavax. At a share price of US$8.45, Novavax has recently seen weaker short term share price returns but a positive year to date share price return and positive multi year total shareholder returns, which suggests...

Earlier this month, National Health Investors, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants, and units, and announced a US$500 million at-the-market follow-on common equity offering structured through an income trust. This combination of a sizable equity program and broad shelf capacity increases the REIT’s funding options and may influence how it balances growth investments with potential dilution and balance sheet...

Eisai and Nuvation Bio (NUVB) just cleared an important hurdle in Europe, with the EMA validating their Marketing Authorisation Application for taletrectinib in advanced ROS1 positive non small cell lung cancer. See our latest analysis for Nuvation Bio. Nuvation Bio’s share price has been volatile around the EMA update, with a 1 day share price return of 3.85% decline and a 30 day share price return of 28.09% decline. However, the 1 year total shareholder return of 133.52% and 3 year total...

Insider selling raises questions around Agnico Eagle Mines (AEM) Recent filings show heavy insider selling at Agnico Eagle Mines (AEM), including US$16m of disposals over the past quarter and an US$8m sale by the CEO, with no offsetting insider purchases reported. See our latest analysis for Agnico Eagle Mines. Against this insider activity, Agnico Eagle Mines’ recent share price moves have been mixed, with a 7.97% 7 day share price return and a 23.13% 30 day share price decline. However, a...

In March 2026, Charter Communications appointed John Lee to lead a new Intelligence Ventures unit focused on privacy-safe, AI-driven data products, while also rolling out a Multiview feature in the Spectrum TV App that lets viewers watch up to four live basketball games at once. These moves toward data-led advertising solutions and enhanced viewing experiences arrive as Charter contends with substantial video and internet subscriber losses, call center closures and layoffs linked to its...

BlackLine (BL) has just expanded its share repurchase authorization by US$100 million to US$500 million and added two directors, moves that frame how management is thinking about capital allocation and future execution. See our latest analysis for BlackLine. BlackLine’s share price has been under pressure, with a 1-day share price return showing a 4.02% decline and a 7-day share price return showing a 7.82% decline. The 1-year total shareholder return shows a 26.14% decline, indicating that...